Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD, USA.
Medic Clinic III, Department of Nephrology, University Hospital Frankfurt, Goethe-University, Frankfurt, Germany.
Nat Immunol. 2022 Jan;23(1):62-74. doi: 10.1038/s41590-021-01080-3. Epub 2021 Nov 11.
The molecular mechanisms governing orderly shutdown and retraction of CD4 type 1 helper T (T1) cell responses remain poorly understood. Here we show that complement triggers contraction of T1 responses by inducing intrinsic expression of the vitamin D (VitD) receptor and the VitD-activating enzyme CYP27B1, permitting T cells to both activate and respond to VitD. VitD then initiated the transition from pro-inflammatory interferon-γ T1 cells to suppressive interleukin-10 cells. This process was primed by dynamic changes in the epigenetic landscape of CD4 T cells, generating super-enhancers and recruiting several transcription factors, notably c-JUN, STAT3 and BACH2, which together with VitD receptor shaped the transcriptional response to VitD. Accordingly, VitD did not induce interleukin-10 expression in cells with dysfunctional BACH2 or STAT3. Bronchoalveolar lavage fluid CD4 T cells of patients with COVID-19 were T1-skewed and showed de-repression of genes downregulated by VitD, from either lack of substrate (VitD deficiency) and/or abnormal regulation of this system.
调控有序的 CD4 型 1 辅助性 T(T1)细胞反应的关闭和收缩的分子机制仍知之甚少。在这里,我们发现补体通过诱导维生素 D(VitD)受体和 VitD 激活酶 CYP27B1 的内在表达来触发 T1 反应的收缩,从而使 T 细胞既能激活又能对 VitD 作出反应。VitD 随后启动了从促炎的干扰素-γ T1 细胞向抑制性白细胞介素-10 细胞的转变。这个过程由 CD4 T 细胞表观遗传景观的动态变化引发,生成超级增强子并招募了几个转录因子,特别是 c-JUN、STAT3 和 BACH2,它们与 VitD 受体一起塑造了对 VitD 的转录反应。因此,VitD 不会诱导 BACH2 或 STAT3 功能失调的细胞产生白细胞介素-10 表达。COVID-19 患者的支气管肺泡灌洗液 CD4 T 细胞呈 T1 偏向性,并表现出 VitD 下调基因的去抑制,这可能是由于缺乏底物(VitD 缺乏)和/或该系统的异常调节。